{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:47:08Z","timestamp":1783619228483,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a complex and multi-faceted endocrine disorder that affects 5\u201320% of women. Literature is limited regarding potentially differing PCOS phenotypes among women around the world.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To use Flo app technology to understand the multifaceted characteristics of PCOS across several countries and identify contributing risk factors to the development of this condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Flo is a widely used female health and wellbeing app with period tracking functionality that provides a globally representative and medically unbiased perspective on PCOS symptomatology. A chatbot dialog on PCOS was subsequently administered on the Flo application (app) to users from 142 countries (with at least 100 respondents) who have the app running in English during September\u2013October 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For analyses, we selected the five countries with the greatest number of respondents: US (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009243,238), UK (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200968,325), India (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940,092), Philippines (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935,131), and Australia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200929,926). Bloating was the most frequently reported symptom among PCOS-positive women and appeared to be the main predictor of PCOS in our model (odds ratio 3\u00b776 [95% CI 3\u00b760\u20133\u00b794];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090\u00b70001). Additional top predictors of PCOS are high blood cholesterol and glucose levels. As BMI increased, the percentage of women who reported a physician-confirmed PCOS diagnosis also increased. However, women in India did not follow this trend.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings are based on the largest known PCOS dataset and indicate that symptoms are more complex than previously understood. The most frequently reported symptoms (bloating, facial hirsutism, irregular cycles, hyperpigmentation, and baldness) are broader than those included in the Rotterdam criteria. Future work should reevaluate and refine the criteria utilized in PCOS diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-021-00719-y","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T04:06:19Z","timestamp":1614744379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Characterization of polycystic ovary syndrome among Flo app users around the world"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8889-084X","authenticated-orcid":false,"given":"Tarun","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Negris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannielle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Galic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodion","family":"Salimgaraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Zhaunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"719_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"719_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2009","unstructured":"March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2009;25(2):544\u201351.","journal-title":"Hum Reprod"},{"issue":"1","key":"719_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Group TREA-SPCW","year":"2004","unstructured":"Group TREA-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"1","key":"719_CR4","first-page":"17","volume":"18","author":"M Bani Mohammad","year":"2017","unstructured":"Bani Mohammad M, Majdi SA. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pacific J Cancer Prevent. 2017;18(1):17\u201321.","journal-title":"Asian Pacific J Cancer Prevent"},{"issue":"5","key":"719_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"issue":"11","key":"719_CR6","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metabol. 2006;91(11):4237\u201345.","journal-title":"J Clin Endocrinol Metabol"},{"key":"719_CR7","volume-title":"Pathways to Prevention Workshop Program (P2P): National Institutes of Health","author":"Health NIo","year":"2012","unstructured":"Health NIo. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome (PCOS). In: Pathways to Prevention Workshop Program (P2P): National Institutes of Health; 2012."},{"issue":"2","key":"719_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","volume":"20","author":"BO Yildiz","year":"2006","unstructured":"Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab. 2006;20(2):167\u201376.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"719_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"2","key":"719_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1464727002000198781","volume":"3","author":"S Wild","year":"2000","unstructured":"Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb). 2000;3(2):101\u20135.","journal-title":"Hum Fertil (Camb)"},{"issue":"4","key":"719_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00404-003-0537-2","volume":"270","author":"M Al-Azemi","year":"2004","unstructured":"Al-Azemi M, Omu FE, Omu AE. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2004;270(4):205\u201310.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"719_CR12","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/sj.ijo.0803730","volume":"31","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes. 2007;31(2):S8\u2013S13.","journal-title":"Int J Obes"},{"issue":"2","key":"719_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","volume":"32","author":"D Kiddy","year":"1990","unstructured":"Kiddy D, Sharp P, White D, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol. 1990;32(2):213\u201320.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"719_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2265.1994.tb02578.x","volume":"41","author":"J Holte","year":"1994","unstructured":"Holte J, Bergh T, Gennarelli G, Wide L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol. 1994;41(4):473\u201381.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"719_CR15","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","volume":"10","author":"AH Balen","year":"1995","unstructured":"Balen AH, Conway GS, Kaltsas G, et al. Andrology: polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107\u201311.","journal-title":"Hum Reprod"},{"issue":"6","key":"719_CR16","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.fertnstert.2008.09.003","volume":"92","author":"T-H Liou","year":"2009","unstructured":"Liou T-H, Yang J-H, Hsieh C-H, Lee C-Y, Hsu C-S, Hsu M-I. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2009;92(6):1960\u20135.","journal-title":"Fertil Steril"},{"issue":"4","key":"719_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly NS, Khomami MB, Joham AE, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455\u201367.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"719_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"719_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/oby.2007.527","volume":"15","author":"K Reynolds","year":"2007","unstructured":"Reynolds K, Gu D, Whelton PK, et al. Prevalence and risk factors of overweight and obesity in China. Obesity. 2007;15(1):10\u20138.","journal-title":"Obesity"},{"issue":"3","key":"719_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. Jama. 2010;303(3):235\u201341.","journal-title":"Jama"},{"issue":"2","key":"719_CR21","first-page":"375","volume":"102","author":"M Cree-Green","year":"2017","unstructured":"Cree-Green M. Worldwide dissatisfaction with the diagnostic process and initial treatment of PCOS. J Clin Endocrinol Metab. 2017;102(2):375\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"719_CR22","doi-asserted-by":"publisher","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","volume":"98","author":"U Ezeh","year":"2013","unstructured":"Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(6):E1088\u201396.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"719_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","volume":"78","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013;78(8):755\u201360.","journal-title":"Steroids"},{"key":"719_CR24","doi-asserted-by":"crossref","unstructured":"Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race\/Ethnicity. Int J Environ Res Public Health. 2018;15(11):2589.","DOI":"10.3390\/ijerph15112589"},{"issue":"56","key":"719_CR25","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","volume":"8","author":"T Ding","year":"2017","unstructured":"Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351\u20138.","journal-title":"Oncotarget"},{"issue":"4","key":"719_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/cen.12784","volume":"83","author":"H Mani","year":"2015","unstructured":"Mani H, Davies MJ, Bodicoat DH, et al. Clinical characteristics of polycystic ovary syndrome: investigating differences in White and south Asian women. Clin Endocrinol. 2015;83(4):542\u20139.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"719_CR27","doi-asserted-by":"publisher","first-page":"E2412","DOI":"10.1210\/jc.2014-2703","volume":"99","author":"L Casarini","year":"2014","unstructured":"Casarini L, Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-Wide association studies\u2013based, in silico, evolutionary explanation. J Clin Endocrinol Metabol. 2014;99(11):E2412\u2013E20.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"3","key":"719_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/aje\/kwn137","volume":"168","author":"V Kumarapeli","year":"2008","unstructured":"Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008;168(3):321\u20138.","journal-title":"Am J Epidemiol"},{"issue":"19","key":"719_CR29","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","volume":"166","author":"F \u00c1lvarez-Blasco","year":"2006","unstructured":"\u00c1lvarez-Blasco F, Botella-Carretero JI, San Mill\u00e1n JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166(19):2081\u20136.","journal-title":"Arch Intern Med"},{"issue":"11","key":"719_CR30","doi-asserted-by":"publisher","first-page":"e27455","DOI":"10.1371\/journal.pone.0027455","volume":"6","author":"A von Ruesten","year":"2011","unstructured":"von Ruesten A, Steffen A, Floegel A, et al. Trend in obesity prevalence in European adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS One. 2011;6(11):e27455.","journal-title":"PLoS One"},{"issue":"9","key":"719_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5694\/j.1326-5377.2003.tb05283.x","volume":"178","author":"AJ Cameron","year":"2003","unstructured":"Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). Med J Aust. 2003;178(9):427\u201332.","journal-title":"Med J Aust"},{"issue":"9793","key":"719_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804\u201314.","journal-title":"Lancet"},{"issue":"3","key":"719_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7555\/JBR.30.20140111","volume":"30","author":"C Yuan","year":"2016","unstructured":"Yuan C, Liu X, Mao Y, Diao F, Cui Y, Liu J. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study. J Biomed Res. 2016;30(3):197\u2013202.","journal-title":"J Biomed Res"},{"issue":"10","key":"719_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1600-0412.2012.01417.x","volume":"91","author":"SJ Liang","year":"2012","unstructured":"Liang SJ, Liou TH, Lin HW, Hsu CS, Tzeng CR, Hsu MI. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2012;91(10):1167\u201372.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"719_CR35","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metabol. 1999;84(1):165\u20139.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"719_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/jc.2005-1329","volume":"91","author":"DA Ehrmann","year":"2006","unstructured":"Ehrmann DA, Liljenquist DR, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2006;91(1):48\u201353.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"11","key":"719_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/01.ogx.0000243772.33357.84","volume":"61","author":"MJ Himelein","year":"2006","unstructured":"Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstetrical Gynecol Surv. 2006;61(11):723\u201332.","journal-title":"Obstetrical Gynecol Surv"},{"issue":"9","key":"719_CR38","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/humrep\/der197","volume":"26","author":"JA Barry","year":"2011","unstructured":"Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442\u201351.","journal-title":"Hum Reprod"},{"issue":"6","key":"719_CR39","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/01.JIM.0000446834.90599.5d","volume":"62","author":"SM Sirmans","year":"2014","unstructured":"Sirmans SM, Parish RC, Blake S, Wang X. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population. J Investig Med. 2014;62(6):868\u201374.","journal-title":"J Investig Med"},{"issue":"1","key":"719_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6\u201315.","journal-title":"Fertil Steril"},{"issue":"3","key":"719_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/eb-2018-102891","volume":"21","author":"J Torous","year":"2018","unstructured":"Torous J, Nicholas J, Larsen ME, Firth J, Christensen H. Clinical review of user engagement with mental health smartphone apps: evidence, theory and improvements. Evidence-based mental health. 2018;21(3):116\u20139.","journal-title":"Evidence-based mental health"},{"issue":"1","key":"719_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41746-019-0152-7","volume":"2","author":"JR Bull","year":"2019","unstructured":"Bull JR, Rowland SP, Scherwitzl EB, Scherwitzl R, Danielsson KG, Harper J. Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. npj Digital Med. 2019;2(1):83.","journal-title":"npj Digital Med"},{"key":"719_CR43","unstructured":"Dreaper J. Women warned about booming market in period tracker apps. BBC News. 2016;2016. https:\/\/www.bbc.com\/news\/health-37013217. Accessed 19 Feb 2021."}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-021-00719-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T05:36:45Z","timestamp":1697953005000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-021-00719-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1186\/s12958-021-00719-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-131934\/v1","asserted-by":"object"}]},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study conducted received Northwestern University IRB approval (STU00210811). The committee reviewed the study and assigned a determination of Not Human Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All listed authors provide consent for this manuscript to be published in <i>Reproductive Biology and Endocrinology.<\/i>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}